Krishna Vaddi, CEO: Prelude Therapeutics PRLD Buy · Filed 25/03/27

Trade details

Type: Insider buy
Amount: $465,750
Shares · price: 675,000 sh · $0.69 a share
Held after: 1,999,296 sh
Stock: Prelude Therapeutics PRLD
Person: Krishna VaddiCEO
Trade date: 25/03/25
Filed: 25/03/27
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +51.0%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/23~25/04/24

Krishna Vaddi's recent trades

Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$11K
15,000 sh
$11K
Filed 25/03/24
Traded 25/03/21
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$3,954
5,416 sh
$3,954
Filed 25/03/24
Traded 25/03/20
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$22.5K
29,999 sh
$22.5K
Filed 25/03/18
Traded 25/03/14
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$6,830
9,106 sh
$6,830
Filed 25/03/18
Traded 25/03/17
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$36K
50,000 sh
$36K
Filed 25/03/14
Traded 25/03/13